Eyal Lapidot - Delek CEO
DLEKG Stock | ILS 45,030 400.00 0.88% |
CEO
Mr. Eyal Lapidot serves as Chief Executive Officer of a Subsidiary of Delek Group Ltd. since July 17, 2005. The subsidiary is called the Phoenix Holdings Ltd. His work experience includes the following roles Chief Executive Officer of The Phoenix Insurance Company Ltd., Director at some subsidiaries of the Phoenix group of companies and Chief Executive Officer at Direct I.D.I Insurance Company Ltd since 2005.
Age | 52 |
Tenure | 19 years |
Professional Marks | MBA |
Phone | 972 9 863 8444 |
Web | https://www.delek-group.com |
Delek Management Efficiency
The company has return on total asset (ROA) of 0.1649 % which means that it generated a profit of $0.1649 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7063 %, meaning that it generated $0.7063 on every $100 dollars invested by stockholders. Delek's management efficiency ratios could be used to measure how well Delek manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | CEO Age | ||
Rakefet RussakAminoach | Bank Leumi Le Israel | 51 | |
Ron Fainaro | Bank Leumi Le Israel | 47 | |
Gil Sharon | Bezeq Israeli Telecommunication | 51 | |
Zeev Morag | Bank Leumi Le Israel | 42 | |
Avner Mendelson | Bank Leumi Le Israel | 48 | |
David Maimon | El Al Israel | 56 | |
Stella Handler | Bezeq Israeli Telecommunication | 55 | |
Ran Guron | Bezeq Israeli Telecommunication | 55 | |
Daniel Tsiddon | Bank Leumi Le Israel | 59 | |
Sigurdur Olafsson | Teva Pharmaceutical Industries | 46 | |
Mordechay Elmaliach | Bezeq Israeli Telecommunication | 57 | |
Carlo Notaristefani | Teva Pharmaceutical Industries | 60 | |
Erez Vigodman | Teva Pharmaceutical Industries | 55 | |
Hanan Friedman | Bank Leumi Le Israel | 52 | |
Ron Eilon | Bezeq Israeli Telecommunication | 52 | |
Kaare Schultz | Teva Pharmaceutical Industries | 58 | |
David Mizrahi | Bezeq Israeli Telecommunication | 53 | |
Robert Koremans | Teva Pharmaceutical Industries | 54 |
Management Performance
Return On Equity | 0.71 | |||
Return On Asset | 0.16 |
Delek Group Leadership Team
Elected by the shareholders, the Delek's board of directors comprises two types of representatives: Delek inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Delek. The board's role is to monitor Delek's management team and ensure that shareholders' interests are well served. Delek's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Delek's outside directors are responsible for providing unbiased perspectives on the board's policies.
Barak Mashraki, CFO and Executive VP | ||
Lena Bernstein, Chief Accountant | ||
Moshe Amit, Director | ||
Gilad Meirson, Chairman Limited | ||
Amir Lang, VP of Bus. Devel.s, Mergers and Procurement | ||
Idan Vales, Director | ||
Gali Gana, Internal Auditor | ||
Stu Schapiro, CoChief Ltd | ||
Asaf Bartfeld, CEO and Presidentident | ||
Itshak Sharon, Director | ||
Yitzhak Oz, CoChief Ltd | ||
Eyal Lapidot, CEO of Phoenix Insurance and CEO of Phoenix Holdings Ltd. | ||
Arie Zief, External Director | ||
Shmuel Antzel, CEO at Delek Group Ltd.'s subsidiary, Delek The Israel Oil Corp Ltd. | ||
Yehudit Tytelman, External Director | ||
CecileEsther Eldan, CEO of 2 Subsidiaries of the Company | ||
Ron Milo, Independent Director | ||
Leslie Thomas, CEO of a Subsidiary | ||
Tamar Rosenberg, Controller | ||
Leora Levin, Chief General Counsel, Executive VP and Secretary | ||
Arie Zeif, External Director | ||
Gideon Tadmor, General Manager Oil/Gas Exploration/Transportation | ||
Tamir Polikar, Deputy VP | ||
Idan Wallace, Executive Vice President | ||
Avraham Harel, Director | ||
Yossi Abu, Chief Ltd | ||
Amit Kornhauser, Controller | ||
Moni Feller, CoChief Ltd | ||
Yosef Abu, CEO of a Subsidiary of the Company | ||
Gabriel Last, Chairman of the Board | ||
Advocate Wallace, Pres CEO | ||
Yehudit TytelmanZiedenberg, External Director | ||
Carmit Elroy, Director | ||
Shimon Doron, External Director |
Delek Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Delek a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.71 | |||
Return On Asset | 0.16 | |||
Profit Margin | 0.48 % | |||
Operating Margin | 0.96 % | |||
Current Valuation | 23.6 B | |||
Shares Outstanding | 17.78 M | |||
Shares Owned By Insiders | 48.72 % | |||
Shares Owned By Institutions | 8.37 % | |||
Price To Book | 0.93 X | |||
Price To Sales | 0.69 X |
Pair Trading with Delek
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Delek position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Delek will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Delek could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Delek when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Delek - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Delek Group to buy it.
The correlation of Delek is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Delek moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Delek Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Delek can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Delek Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Delek Group information on this page should be used as a complementary analysis to other Delek's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Delek Stock analysis
When running Delek's price analysis, check to measure Delek's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delek is operating at the current time. Most of Delek's value examination focuses on studying past and present price action to predict the probability of Delek's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delek's price. Additionally, you may evaluate how the addition of Delek to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |